TY - JOUR
T1 - Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography
AU - Ishigami, Kousei
AU - Pakalniskis, Marius G.
AU - Leite, Leandro V.
AU - Lee, Daniel K.
AU - Holanda, Danniele G.
AU - Rajput, Maheen
PY - 2015/1/1
Y1 - 2015/1/1
N2 - The purpose of this study was to assess the characterization of renal cell carcinoma (RCC) and benign renal tumors by unenhanced, nephrographic, and delayed phase computed tomography (CT). The study group consisted of 129 renal tumors including 79 clear cell RCCs, 17 papillary RCCs, 6 chromophobe RCCs, 21 oncocytoma, and 6 lipid-poor angiomyolipomas (AMLs). CT studies were retrospectively reviewed. Our results suggested that it was possible to discriminate clear cell RCC from papillary RCC, chromophobe RCC, and lipid-poor AML. CT findings of oncocytoma overlapped with both clear cell and non-clear cell RCCs, although oncocytoma more commonly became homogeneous in the delayed phase.
AB - The purpose of this study was to assess the characterization of renal cell carcinoma (RCC) and benign renal tumors by unenhanced, nephrographic, and delayed phase computed tomography (CT). The study group consisted of 129 renal tumors including 79 clear cell RCCs, 17 papillary RCCs, 6 chromophobe RCCs, 21 oncocytoma, and 6 lipid-poor angiomyolipomas (AMLs). CT studies were retrospectively reviewed. Our results suggested that it was possible to discriminate clear cell RCC from papillary RCC, chromophobe RCC, and lipid-poor AML. CT findings of oncocytoma overlapped with both clear cell and non-clear cell RCCs, although oncocytoma more commonly became homogeneous in the delayed phase.
UR - http://www.scopus.com/inward/record.url?scp=84916198801&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84916198801&partnerID=8YFLogxK
U2 - 10.1016/j.clinimag.2014.09.008
DO - 10.1016/j.clinimag.2014.09.008
M3 - Article
C2 - 25457535
AN - SCOPUS:84916198801
SN - 0899-7071
VL - 39
SP - 76
EP - 84
JO - Clinical Imaging
JF - Clinical Imaging
IS - 1
ER -